REDACTED Certain identified information, indicated by [*****], has been excluded from the exhibit because it is both (i) not material and (ii) would likely cause competitive harm if publicly disclosed. dated APRIL 2, 2021 by and between CUREVAC AG and...2020 Cla Amendment and Restatement Agreement • April 27th, 2021 • CureVac N.V. • Pharmaceutical preparations
NOW THEREFORE, in consideration of the foregoing premises and the following mutual covenants and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the Parties agree as follows:
